Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis

Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis

Background: Several phase-II trials have been designed to evaluate tyrosine kinase inhibitors (TKIs), in particular, pazopanib in neuroendocrine neoplasia (NEN), but its efficacy has not yet been demonstrated in a randomised-controlled Phase III trial. A systematic review of the published clinical t...

Full description

Bibliographic Details
Main Authors: Alberto Bongiovanni, Chiara Liverani, Federica Recine, Valentina Fausti, Laura Mercatali, Alessandro Vagheggini, Chiara Spadazzi, Giacomo Miserocchi, Claudia Cocchi, Giandomenico Di Menna, Alessandro De Vita, Stefano Severi, Silvia Nicolini, Toni Ibrahim
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Oncology
Subjects:
pazopanib
neuroendocrine neoplasia
neuroendocrine tumours
review
carcinoid
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00414/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.00414/full

Similar Items